Author

Kendall E. Barrett

University of Wisconsin–MadisonORCID 0000-0002-1543-9986Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:imaging· 1 Organism:mouse· 1 Organism:non-human primate· 1 Assay:proteomics· 1

Frequent Co-Authors

Aaron Matthew LeBeauiD· 2 shared Bryan P. BednarziD· 2 shared Eduardo Aluicio‐SarduyiD· 2 shared Jason C. MixdorfiD· 2 shared Jonathan W. EngleiD· 2 shared Joseph P. GallantiD· 2 shared Kendahl L. OttiD· 2 shared Ohyun KwoniD· 2 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Aaron Matthew LeBeauORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Tuning the Structural Properties of a Single-Domain Antibody Scaffold for Improved Fibroblast Activation Protein Targeting

Kendahl L. Ott, Joseph P. Gallant, Ohyun Kwon, Adedamola O. Adeniyi, Kendall E. Barrett, Zachary T. Rosenkrans, Jason C. Mixdorf, Eduardo Aluicio‐Sarduy, Jonathan W. Engle, Reinier T. Hernandez, Bryan P. Bednarz, Aaron Matthew LeBeau

This study engineers single-domain antibodies to improve targeting of FAP, showing that valency and molecular weight affect tumor uptake and biodistribution.

bioRxiv · Mar 13, 2026 · PreprintCancer Biology

A MET-Targeted Variable New Antigen Receptor Theranostic for Non-Small Cell Lung Cancer

Rachel L. Minne, Jayden L. West, Natalie Y. Luo, Kwangok P. Nickel, Gihan S. Gunaratne, Kendahl L. Ott, Joseph P. Gallant, Kendall E. Barrett, Caroline Mörk, Saahil Javeri, Madalynn R. Wopat, Loren D. Rivera Lopez, Will Toscano, Nina C. Zitzer, Ohyun Kwon, , Aaron Matthew LeBeau

This paper develops a shark-derived VNAR-based theranostic agent for MET-altered NSCLC, showing imaging and therapeutic efficacy in preclinical models.

bioRxiv · Mar 11, 2026 · PreprintCancer Biology